COVID-19 associated nervous system manifestations

Sleep Med. 2022 Mar:91:231-236. doi: 10.1016/j.sleep.2021.07.005. Epub 2021 Jul 9.

Abstract

The novel coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a global pandemic in the last year. Along with major respiratory distress, a myriad of neurological manifestations was also reported to be associated with COVID-19 patients. These cases indicate that SARS-CoV-2 can be considered as an opportunistic pathogen of the brain. SARS-CoV-2 enters the brain through the olfactory bulb, retrograde axonal transport from peripheral nerve endings, or via hematogenous or lymphatic routes. Notably, COVID-19 infection can cause or even present with different neurological features including encephalopathy, impaired consciousness, confusion, agitation, seizure, ataxia, headache, anosmia, ageusia, neuropathies, and neurodegenerative diseases. In this paper, we provide a brief review of observed neurological manifestations associated with COVID-19.

Keywords: COVID-19; Neurodegenerative diseases; Neuroinvasion; Neurological manifestations; SARS-CoV-2; Sleep.

MeSH terms

  • Brain
  • COVID-19* / complications
  • Humans
  • Pandemics
  • SARS-CoV-2
  • Seizures